The global vaccine market size is expected to reach USD 77.90 Billion at a steady revenue CAGR of 7.1% in 2028, according to latest analysis by Emergen Research. An increase in prevalence of infectious diseases is a key factor driving global vaccine market revenue growth. Global Vaccine market growth is driven by a variety of factors and trends, primary of which include rising focus by major companies on product/service expansion into new and untapped domestic Vaccine markets, rising investments in strategic agreements, and rising competition in the market. The latest report provides detailed insights into Vaccine market trends, industry trends, consumer trends, market size, market share, market growth, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2024–2028. The report includes profiles of major players in the Vaccine market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.
Have Queries? To request a sample or speak to an expert before you buy the report, click on the link below: https://www.emergenresearch.com/request-sample/290
Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Vaccine Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is a major trend in an increasing number of developing economies. In addition, availability of favorable government policies and steady economic growth across various regions and countries is resulting in an increasing number of players focusing on leveraging opportunities to drive visibility and increase revenue and profits.
Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/vaccine-market
Some Key Highlights From the Report
- In August 2024, Pfizer and BioNTech announced a collaboration with Brazil’s Eurofarma to manufacture COVID-19 vaccine doses for Latin American countries. COMIRNATY will be manufactured by Eurofarma with Pfizer’s and BioNTech’s COVID-19 vaccine manufacturing and supply chain network. Eurofarma will get raw materials for the drug from the U.S. and manufacturing will begin in 2024. Vaccine production is expected to exceed 100 million finished doses yearly which will be exclusively distributed within Latin America.
- Monovalent vaccine segment revenue is expected to register a significant growth rate during the forecast period. A monovalent vaccine is designed to immunize single microorganism and antigen (for example, measles vaccine). This type of vaccine is preferable for development of a strong immune response.
- Toxoid vaccines are administered to adults as well as children to protect them against tetanus and diphtheria. This vaccine is administered to induce an immune response to protect against disease caused by toxins secreted by specific bacteria. This vaccine is part of a course of multiple doses and booster shots are given when travelling to high-risk countries.
Region wise performance of the Vaccine industry
North America Vaccine market growth registered a significant incline in 2024 and this is having major impact on market growth of other major regions. In addition, North America Vaccine market growth is expected to continue to remain dominant over other regional markets over the forecast period. Presence of major players in countries in the region is a key factor driving steady change in overall Vaccine market trends, and this is expected to continue to support market growth in North America.
Asia Pacific Vaccine market growth is expected to register a rapid rate in terms of revenue as compared to other regional markets over the forecast period. China, India, and South Korea accounted for significantly robust Vaccine market growth in 2024, and the trend is expected to continue over the forecast period. Factors such as increasing population, favorable government policies and initiatives, and availability of more advanced technologies, services, and offerings in these countries is driving Vaccine market growth in Asia Pacific.
Europe Vaccine market growth and revenue expansion is expected to remain steady over the forecast period. This can be attributed to robust focus on research and development initiatives by major firms and changing Vaccine market trends in countries in other major regions.
We can customize our reports for our customers, for instance, we can add or remove manufacturers, applications or product types, whatever you need in the report. Ask for it by contacting us@ https://www.emergenresearch.com/request-for-customization/290
Table of Content
Chapter 1. Methodology & Sources
1.1. Vaccine Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Vaccine Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2024-2028
Chapter 3. Key Insights
Chapter 4. Vaccine Market Segmentation & Impact Analysis
4.1. Vaccine Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Vaccine Market indicators analysis
4.2.2. Vaccine Market drivers analysis
4.2.2.1. Rapid urbanization and industrialization
4.2.2.2. Stringent government regulations regarding carbon emissions
4.2.2.3. Increasing prevalence of respiratory diseases
4.2.2.4. Rising need to enhance indoor air quality
4.2.3. Vaccine Market restraints analysis
4.2.3.1. High cost associated with the maintenance of Vaccine products
4.2.3.2. Availability of renewable sources of energy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 10. Competitive Landscape
10.1. Vaccine Market Revenue Share By Manufacturers
10.2. Mergers & Acquisitions
10.3. Competitor’s Positioning
10.4. Strategy Benchmarking
10.5. Vendor Landscape
10.5.1. Raw Material Suppliers
10.5.1.1. North America
10.5.1.2. Europe
10.5.1.3. Asia Pacific
10.5.1.4. Middle East & Africa
10.5.1.5. Latin America
10.5.2. Distributors
10.5.2.1. North America
10.5.2.2. Europe
10.5.2.3. Asia Pacific
10.5.2.4. Middle East & Africa
10.5.2.5. Latin America
10.5.3. Others
Continued….
Get Your Copy at Discounted Price@ https://www.emergenresearch.com/request-discount/290
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
The research provides answers to the following key questions:
- What will be the growth rate and the market size of the Vaccine industry for the forecast period 2024-2027?
- What are the major driving forces expected to impact the development of the Vaccine market across different regions?
- Who are the major driving forces expected to decide the fate of the Vaccine industry worldwide?
- Who are the prominent market players making a mark in the Vaccine market with their winning strategies?
- Which Vaccine industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
Why Choose Emergen Research?
- Strong Industry Focus
- Extensive Product Offerings
- Customer Research Services
- Robust Research Methodology
- Comprehensive Reports
- Latest Technological Developments
- Value Chain Analysis
- Potential Market Opportunities
- Growth Dynamics
- Quality Assurance
- Post-sales Support
Read similar reports by Emergen Research:
Nanopharmaceutical Drugs Market @: https://www.emergenresearch.com/industry-report/nanopharmaceutical-drugs-market
Clinical Perinatal Software Market @: https://www.emergenresearch.com/industry-report/clinical-perinatal-software-market
Human Microbiome Modulators Market @: https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market
In Silico Drug Discovery Market @: https://www.emergenresearch.com/industry-report/in-silico-drug-discovery-market
Prenatal Testing Market @: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
Blockchain in Genomics Market @: https://www.emergenresearch.com/industry-report/blockchain-in-genomics-market
Industrial Microbiology Market @: https://www.emergenresearch.com/industry-report/industrial-microbiology-market
Hematologic Malignancies Testing Market @: https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market
